Monebo Technologies Secures Series B Financing
Austin, TX, July 25, 2007: Monebo Technologies, a leader in the monitoring and interpretation of the electrical activity of the heart, today announced it has secured Series B financing. The undisclosed sum will be used to accelerate the commercialization of the CardioBelt™ Wireless ECG System, and the ECGAnalyzer™ Interpretation Algorithms.
The round was led by Fairway Medical Technologies, a portfolio company of BCM Technologies, the venture capital subsidiary of Baylor College of Medicine. As a result of this funding round, Leo Womack, Fairway’s Chairman, will join Monebo’s Board of Directors, and
“We believe that a wireless solution to cardiac monitoring will become an integral way for physicians to monitor their patients,” said Leo Womack. The Monebo management team has deep industry knowledge and a successful track record in developing and commercializing
Monebo CEO Dale Misczynski said, “The investment from the group led by Fairway validates Monebo’s vision and execution. Early acceptance of our technology has been very promising, with excitement from patients, physicians, pharmaceutical companies and home health care agencies. Based on our unique software algorithms and hardware design, we have the technology to provide very detailed information to the clinician, enabling the monitoring of heart patients from a remote location, and also the analysis and interpretation of ECGs from any device, including those used for pharmaceutical clinical trials. We are